Tata Consumer, Navin Fluorine, Torrent Pharma, Havells India in focus

Tata Consumer, Navin Fluorine, Torrent Pharma, Havells India in focus


Tata Consumer Products: The company has ceased negotiations with Bisleri regarding a possible transaction and to confirm that the company has not reached any final agreement or binding commitment on this matter.

Navin Fluorine International: The board of Navin Fluorine Advanced Sciences (NFASL), a wholly-owned subsidiary of the company, has approved a capital expenditure of Rs 450 crore to establish a new 40,000 tonnes per year hydrofluoric acid capacity in Dahej.

Torrent Pharmaceuticals: USFDA Conducted Pre-Approval Inspection [PAI] from Oral-Oncology’s manufacturing facility at Bileshwarpura, Gujarat from 13 Mar 2023 to 17 Mar 2023. At the end of the inspection, he issued a ‘Form 483’ with 1 remark, which is procedural in nature.

Havells India: The company started commercial production of air conditioners at its plant in Sri-City, Chittoor District, Andhra Pradesh from March 17, 2023.

SKF India – The company’s board of directors has agreed to make an investment in M/s Cleanmax Taiyo Private Limited (‘the investee company’) by acquiring 2,600 fully paid shares of Rs. 10/- each equivalent to 26% of the total issued and paid-up share capital of the Investee Company.

Rail Vikas Nigam Limited (RVNL): RVNL emerged as the lowest bidder (L1) for the composite contract package in connection with the new BG Railway Line of HORC project. The cost of the project is Rs. 1088.49 crores.

powered by Capital Markets – Live News

(This story has not been edited by Business Standard staff and is automatically generated from a syndicated feed.)


Leave a Comment


No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *